Evidence map›Paper›PMID 24472047›Full record

ReviewThe journal of obstetrics and gynaecology research2014

Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

Giorgio Bogani, Sean C Dowdy, William A Cliby, Fabio Ghezzi, Diego Rossetti, Andrea Mariani

Open access · greenAbstract readReview
In one paragraph

Review in The journal of obstetrics and gynaecology research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Lymphadenectomy for the management of endometrial cancer.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Lymphadenectomy for the management of endometrial cancer.The Cochrane database of systematic reviews · 2015
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Endometrial carcinoma: use of tracer kinetic modeling of dynamic contrast-enhanced MRI for preoperative risk assessment.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Article
  14. Review
  15. Is routine frozen section analysis necessary in patients with non-endometrioid cancer or grade 3 endometrioid cancer?International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022
    Article
  16. Article
  17. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  18. Review
  19. Sentinel lymph node intraoperative analysis in endometrial cancer.Journal of cancer research and clinical oncology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Giorgio BoganiDivision of Gynecologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Sean C Dowdy
William A Cliby
Fabio Ghezzi
Diego Rossetti
Andrea Mariani
Mayo Clinic in Arizona · USMayo Clinic in Florida · USOspedale Papa Giovanni XXIII · ITUniversity of Insubria · IT

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
NCI NIH HHS P30 CA015083
6 · The paper itself

Abstract

The aim of the present review is to summarize the current evidence on the role of pelvic and para-aortic lymphadenectomy in endometrial cancer. In 1988, the International Federation of Obstetrics and Gynecology recommended surgical staging for endometrial cancer patients. However, 25 years later, the role of lymph node dissection remains controversial. Although the findings of two large independent randomized trials suggested that pelvic lymphadenectomy provides only adjunctive morbidity with no clear influence on survival outcomes, the studies have many pitfalls that limit interpretation of the results. Theoretically, lymphadenectomy may help identify patients with metastatic dissemination, who may benefit from adjuvant therapy, thus reducing radiation-related morbidity. Also, lymphadenectomy may eradicate metastatic disease. Because lymphatic spread is relatively uncommon, our main effort should be directed at identifying patients who may potentially benefit from lymph node dissection, thus reducing the rate of unnecessary treatment and associated morbidity. This review will discuss the role of lymphadenectomy in endometrial cancer, focusing on patient selection, extension of the surgical procedure, postoperative outcomes, quality of life and costs. The need for new surgical studies and efficacious systemic drugs is recommended.

Indexed as

Lymph Node ExcisionPatient SelectionAortaEndometrial NeoplasmsFemaleHumansLymphatic MetastasisPelvisQuality of LifeSurvival Rateaortic lymphadenectomyendometrial cancerpelvic lymphadenectomystagingsurvival

Identifiers

PMID24472047
PMCPMC4364412
OpenAlexW1530416404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.